{"schema_version":"secwatch.filing_event.v1","accession":"0001682852-25-000031","form_type":"8-K","ticker":"MRNA","cik":"0001682852","company_name":"Moderna, Inc.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.329807+00:00","generated_at":"2026-05-23T00:42:26.633917+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Moderna Q1 net loss $1.0B, revenue $108M; reiterates 2025 revenue guidance $1.5-2.5B","bullets":["Q1 2025 revenue $108M (down 35% YoY); GAAP net loss $(1.0)B, EPS $(2.52).","Reiterates 2025 revenue guidance $1.5-2.5B; expects H1 revenue ~$0.2B due to seasonality.","Announces cost-cutting plan: reduce GAAP operating costs by $1.4-1.7B by 2027; new 2027 estimate $4.7-5.0B.","Pipeline milestones: next-gen COVID vaccine PDUFA May 31; RSV vaccine PDUFA June 12; flu/COVID combo approval targeted 2026.","Cash and investments $8.4B at March 31 (down from $9.5B at Dec 31); expects year-end ~$6B."],"urls":{"canonical":"https://secwatch.observer/filing/0001682852-25-000031","json":"https://secwatch.observer/filing/0001682852-25-000031.json","markdown":"https://secwatch.observer/filing/0001682852-25-000031.md","text":"https://secwatch.observer/filing/0001682852-25-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000031/0001682852-25-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000031/mrna-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T00:42:26.633917+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}